Show simple item record

Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years

dc.contributor.authorUnuvar, A.
dc.contributor.authorKavakli, K.
dc.date.accessioned2021-03-05T18:55:01Z
dc.date.available2021-03-05T18:55:01Z
dc.identifier.citationKavakli K., Unuvar A., "Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years", HAEMOPHILIA, cilt.25, ss.28, 2019
dc.identifier.issn1351-8216
dc.identifier.othervv_1032021
dc.identifier.otherav_ccae2ec2-d27a-48db-bf89-20b2c793224b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/135496
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectHEMATOLOJİ
dc.titleChanging paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years
dc.typeMakale
dc.relation.journalHAEMOPHILIA
dc.contributor.departmentEge Üniversitesi , ,
dc.identifier.volume25
dc.identifier.startpage28
dc.identifier.endpage28
dc.contributor.firstauthorID262068


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record